Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phenylthiohydantoin | 1 | 2021 | 89 | 0.770 |
Why?
|
| Androgen Antagonists | 2 | 2021 | 411 | 0.670 |
Why?
|
| Glycolysis | 1 | 2021 | 519 | 0.640 |
Why?
|
| Androgens | 5 | 2022 | 511 | 0.630 |
Why?
|
| Acetyltransferases | 3 | 2015 | 143 | 0.600 |
Why?
|
| Nitriles | 2 | 2021 | 906 | 0.580 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2021 | 425 | 0.570 |
Why?
|
| Prostatic Neoplasms | 11 | 2022 | 5767 | 0.550 |
Why?
|
| Benzamides | 1 | 2021 | 1832 | 0.540 |
Why?
|
| Oxidative Stress | 4 | 2010 | 1129 | 0.530 |
Why?
|
| Mitochondria | 1 | 2021 | 1282 | 0.480 |
Why?
|
| Prostate | 2 | 2015 | 1088 | 0.430 |
Why?
|
| Reactive Oxygen Species | 7 | 2015 | 987 | 0.360 |
Why?
|
| Putrescine | 1 | 2009 | 17 | 0.360 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2009 | 28 | 0.360 |
Why?
|
| Vitamin E | 1 | 2010 | 136 | 0.360 |
Why?
|
| Hydroxamic Acids | 1 | 2010 | 442 | 0.300 |
Why?
|
| Proto-Oncogene Proteins c-jun | 4 | 2014 | 166 | 0.300 |
Why?
|
| Antioxidants | 1 | 2010 | 507 | 0.290 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2010 | 612 | 0.280 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 5112 | 0.250 |
Why?
|
| Antineoplastic Agents | 4 | 2021 | 14289 | 0.250 |
Why?
|
| Polyamines | 1 | 2003 | 75 | 0.230 |
Why?
|
| Cyclopropanes | 1 | 2003 | 88 | 0.230 |
Why?
|
| Receptors, Androgen | 4 | 2022 | 878 | 0.220 |
Why?
|
| Benzeneacetamides | 1 | 2021 | 28 | 0.200 |
Why?
|
| Thiadiazoles | 1 | 2021 | 47 | 0.200 |
Why?
|
| Cell Line, Tumor | 10 | 2022 | 14551 | 0.190 |
Why?
|
| Cell Survival | 2 | 2021 | 3045 | 0.140 |
Why?
|
| Thiones | 1 | 2015 | 16 | 0.130 |
Why?
|
| Lactams | 1 | 2015 | 24 | 0.130 |
Why?
|
| Macrolides | 1 | 2015 | 62 | 0.130 |
Why?
|
| Prodrugs | 1 | 2015 | 217 | 0.120 |
Why?
|
| Disease Progression | 3 | 2015 | 6682 | 0.110 |
Why?
|
| Thiazoles | 1 | 2015 | 726 | 0.100 |
Why?
|
| Adenocarcinoma | 1 | 2009 | 7789 | 0.100 |
Why?
|
| Male | 12 | 2022 | 123000 | 0.090 |
Why?
|
| Neoplasm Grading | 1 | 2015 | 1742 | 0.090 |
Why?
|
| Prostatectomy | 1 | 2015 | 962 | 0.090 |
Why?
|
| Chromatography, Liquid | 1 | 2010 | 342 | 0.080 |
Why?
|
| Transcription Factor AP-1 | 2 | 2008 | 246 | 0.080 |
Why?
|
| Mass Spectrometry | 1 | 2010 | 702 | 0.080 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2015 | 624 | 0.070 |
Why?
|
| Drug Synergism | 1 | 2010 | 1313 | 0.070 |
Why?
|
| Stereoisomerism | 2 | 2003 | 164 | 0.070 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2008 | 342 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2015 | 6150 | 0.070 |
Why?
|
| RNA, Small Interfering | 2 | 2009 | 2216 | 0.070 |
Why?
|
| Structure-Activity Relationship | 2 | 2003 | 931 | 0.060 |
Why?
|
| Humans | 12 | 2022 | 261506 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 7548 | 0.060 |
Why?
|
| Propylamines | 1 | 2003 | 12 | 0.060 |
Why?
|
| Indicators and Reagents | 1 | 2003 | 128 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 5159 | 0.060 |
Why?
|
| Cell Division | 2 | 2003 | 2489 | 0.050 |
Why?
|
| Colonic Neoplasms | 1 | 2010 | 1390 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 1879 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2009 | 4143 | 0.050 |
Why?
|
| Steroids | 1 | 2022 | 356 | 0.050 |
Why?
|
| Neoplasm Transplantation | 1 | 2003 | 1519 | 0.050 |
Why?
|
| Mice | 3 | 2022 | 34495 | 0.050 |
Why?
|
| Body Weight | 1 | 2003 | 1293 | 0.040 |
Why?
|
| Testosterone | 1 | 2022 | 619 | 0.040 |
Why?
|
| DNA | 2 | 2022 | 2693 | 0.040 |
Why?
|
| Prognosis | 1 | 2015 | 21713 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 7222 | 0.040 |
Why?
|
| Animals | 3 | 2022 | 59536 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2010 | 5178 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 5395 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2003 | 4307 | 0.030 |
Why?
|
| Streptomyces | 1 | 2015 | 16 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 29902 | 0.030 |
Why?
|
| Kidney | 1 | 2003 | 2146 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2015 | 515 | 0.030 |
Why?
|
| Liver | 1 | 2003 | 2961 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 4938 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 2864 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2014 | 576 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2008 | 3639 | 0.020 |
Why?
|
| Aged | 1 | 2015 | 70117 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 591 | 0.020 |
Why?
|
| Metribolone | 1 | 2008 | 48 | 0.020 |
Why?
|
| Hormone Antagonists | 1 | 2008 | 101 | 0.020 |
Why?
|
| Middle Aged | 1 | 2015 | 86204 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2008 | 475 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 15694 | 0.020 |
Why?
|
| Fos-Related Antigen-2 | 1 | 2005 | 7 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2008 | 771 | 0.020 |
Why?
|
| Tosyl Compounds | 1 | 2005 | 40 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2005 | 191 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2005 | 342 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2010 | 1620 | 0.020 |
Why?
|
| Base Sequence | 1 | 2010 | 4917 | 0.010 |
Why?
|
| Transfection | 1 | 2008 | 2944 | 0.010 |
Why?
|
| Anilides | 1 | 2005 | 268 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 3101 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2008 | 1694 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 6089 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2015 | 7226 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2008 | 3536 | 0.010 |
Why?
|
| Gene Expression | 1 | 2010 | 3570 | 0.010 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2003 | 566 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2022 | 37905 | 0.010 |
Why?
|
| Apoptosis | 1 | 2014 | 7591 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2005 | 2084 | 0.010 |
Why?
|
| Female | 1 | 2010 | 141928 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2005 | 3033 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 3154 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 4821 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2005 | 5270 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 12926 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2005 | 11965 | 0.000 |
Why?
|